Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review

Health Economics
Tom L DrakeYoel Lubell

Abstract

Economic evaluation using dynamic transmission models is important for capturing the indirect effects of infectious disease interventions. We examine the use of these methods in low- and middle-income countries, where infectious diseases constitute a major burden. This review is comprised of two parts: (1) a summary of dynamic transmission economic evaluations across all disease areas published between 2011 and mid-2014 and (2) an in-depth review of mosquito-borne disease studies focusing on health economic methods and reporting. Studies were identified through a systematic search of the MEDLINE database and supplemented by reference list screening. Fifty-seven studies were eligible for inclusion in the all-disease review. The most common subject disease was HIV/AIDS, followed by malaria. A diverse range of modelling methods, outcome metrics and sensitivity analyses were used, indicating little standardisation. Seventeen studies were included in the mosquito-borne disease review. With notable exceptions, most studies did not employ economic evaluation methods beyond calculating a cost-effectiveness ratio or net benefit. Many did not adhere to health care economic evaluations reporting guidelines, particularly with respect to fu...Continue Reading

References

Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Mar 9, 2006·Health Affairs·Ramanan LaxminarayanDavid L Smith
Aug 26, 2006·The American Journal of Tropical Medicine and Hygiene·Fabrizio TediosiMarcel Tanner
Jun 10, 2009·Malaria Journal·Fabrizio TediosiThomas A Smith
Apr 28, 2010·The Journal of Physical Chemistry. a·Genyuan LiJacqueline Schoendorf
Feb 8, 2011·Journal of the Royal Society, Interface·Luis R CarrascoAlex R Cook
Mar 31, 2011·Sexually Transmitted Infections·Shankar PrinjaRajesh Kumar
Apr 21, 2011·PharmacoEconomics·Mark Jit, Marc Brisson
Jun 17, 2011·The Journal of Infectious Diseases·David BishaiAlya Dabbagh
Jun 17, 2011·The Journal of Infectious Diseases·Joseph B BabigumiraAlya Dabbagh
Jun 17, 2011·The Journal of Infectious Diseases·Ann LevinAlya Dabbagh
Oct 15, 2011·International Journal of STD & AIDS·E A EnnsE Bendavid
Feb 15, 2012·Human Vaccines & Immunotherapeutics·Norberto GiglioPascal Crépey
Apr 5, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle P WalenskyA David Paltiel
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Richard PitmanUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Dec 12, 2012·Proceedings of the National Academy of Sciences of the United States of America·Till BärnighausenSalal Humair
Jan 4, 2013·Bulletin of the World Health Organization·Tom L DrakeRichard Coker
Jan 5, 2013·Journal of the Royal Society, Interface·Patricia L M LeeGraeme C Hays
Jan 12, 2013·Bio Systems·Kazeem O OkosunNizar Marcus
Feb 15, 2013·Journal of the Royal Society, Interface·Robert C ReinerDavid L Smith
Mar 26, 2013·Journal of Medical Economics·Don HusereauUNKNOWN CHEERS Task Force
Mar 28, 2013·BMC Medicine·Don HusereauUNKNOWN CHEERS Task Force
Apr 17, 2013·Journal of General Internal Medicine·Elisa F Long, Robert R Stavert
Apr 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Martial L Ndeffo MbahAlison P Galvani
May 30, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Masaya KatoBrian Williams
Jun 5, 2013·Journal of Biological Physics·Kazeem Oare Okosun, Oluwole Daniel Makinde

❮ Previous
Next ❯

Citations

Jan 21, 2017·Applied Health Economics and Health Policy·Tom L Drake, Yoel Lubell
Jul 25, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Samuel N FrempongPelham Barton
Aug 14, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Klas KellerborgPieter van Baal
Dec 1, 2017·PLoS Medicine·UNKNOWN malERA Refresh Consultative Panel on Combination Interventions and Modelling
Aug 11, 2020·Cost Effectiveness and Resource Allocation : C/E·Liv Nymark, Anna Vassall
Aug 25, 2020·European Journal of Operational Research·Sheetal Prakash Silal, UNKNOWN Modelling and Simulation Hub, Africa (MASHA)
Aug 4, 2021·Brazilian Journal of Physical Therapy·Gisela Cristiane MiyamotoJohanna Maria van Dongen
Nov 1, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Anton L V Avanceña, David W Hutton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.